Thank you expressing interest in the research by VitroScan and collaborating Principle Investigators on ex vivo prediction of clinical response to carboplatin-paclitaxel for ovarian cancer patients. This poster is presented by dr. Nelleke Ottevanger on June 5, 2023, from 1:15-4:15 PM, at poster board number 258 in the Gynecologic Cancer session.

VitroScan is represented by Willemijn Vader and Donny van der Meer at this poster presentation.

Please find our poster here

Willemijn Vader (CEO)

     willemijn.vader@vitroscan.nl 

      Connect on LinkedIn

Donny van der Meer (Senior Scientist Bioinformatics)

     donny@vitroscan.nl

To discuss applications in clinical trials, please contact us here.